company background image
SALR

SALUS Ljubljana d. d LJSE:SALR Stock Report

Last Price

€1.42k

Market Cap

€148.2m

7D

0%

1Y

2.2%

Updated

17 Aug, 2022

Data

Company Financials
SALR fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends4/6

SALR Stock Overview

SALUS, Ljubljana, d. d. engages in the provision of distribution, promotion, active sales, and value-added services for the medicinal products, dietary supplements, or medical devices in Slovenia and internationally.

SALUS Ljubljana d. d Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SALUS Ljubljana d. d
Historical stock prices
Current Share Price€1,420.00
52 Week High€1,490.00
52 Week Low€1,260.00
Beta0.57
1 Month Change-3.40%
3 Month Change2.16%
1 Year Change2.16%
3 Year Change115.15%
5 Year Change195.83%
Change since IPO1,583.18%

Recent News & Updates

Jun 02
We Like These Underlying Return On Capital Trends At SALUS Ljubljana d. d (LJSE:SALR)

We Like These Underlying Return On Capital Trends At SALUS Ljubljana d. d (LJSE:SALR)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

May 13
With EPS Growth And More, SALUS Ljubljana d. d (LJSE:SALR) Is Interesting

With EPS Growth And More, SALUS Ljubljana d. d (LJSE:SALR) Is Interesting

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

Apr 22
These 4 Measures Indicate That SALUS Ljubljana d. d (LJSE:SALR) Is Using Debt Reasonably Well

These 4 Measures Indicate That SALUS Ljubljana d. d (LJSE:SALR) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

SALRSI HealthcareSI Market
7D0%0.3%-17.4%
1Y2.2%-33.1%-20.7%

Return vs Industry: SALR exceeded the SI Healthcare industry which returned -33.1% over the past year.

Return vs Market: SALR exceeded the SI Market which returned -20.7% over the past year.

Price Volatility

Is SALR's price volatile compared to industry and market?
SALR volatility
SALR Average Weekly Movementn/a
Healthcare Industry Average Movement4.6%
Market Average Movement3.6%
10% most volatile stocks in SI Market4.3%
10% least volatile stocks in SI Market2.9%

Stable Share Price: Insufficient data to determine SALR's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine SALR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969460n/ahttps://www.salus.si

SALUS, Ljubljana, d. d. engages in the provision of distribution, promotion, active sales, and value-added services for the medicinal products, dietary supplements, or medical devices in Slovenia and internationally. The company offers medicines, medical devices, diagnostic devices, medical supplies, sanitary products, dietary supplements, cosmetic products, pharmaceutical packaging, and other health and well-being related products to pharmacies, hospitals, community health centers, residential homes, veterinary institutions, and other customers. It also provides services, such as warehousing services for medicines and other medicinal products; secondary packaging of medicines and other products; and regulatory services for medicinal products, medical devices, and food supplements.

SALUS Ljubljana d. d Fundamentals Summary

How do SALUS Ljubljana d. d's earnings and revenue compare to its market cap?
SALR fundamental statistics
Market Cap€148.21m
Earnings (TTM)€12.32m
Revenue (TTM)€477.06m

12.0x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SALR income statement (TTM)
Revenue€477.06m
Cost of Revenue€422.96m
Gross Profit€54.10m
Other Expenses€41.77m
Earnings€12.32m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)118.07
Gross Margin11.34%
Net Profit Margin2.58%
Debt/Equity Ratio10.8%

How did SALR perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

55%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is SALR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SALR?

Other financial metrics that can be useful for relative valuation.

SALR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.3x
Enterprise Value/EBITDA8.1x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does SALR's PE Ratio compare to its peers?

SALR PE Ratio vs Peers
The above table shows the PE ratio for SALR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average13.8x
2393 Nippon Care Supply
14.4xn/aJP¥22.9b
3154 Medius Holdings
9.8xn/aJP¥18.2b
PGC Paragon Care
26.3x39.9%AU$222.3m
PHARMA Pharmaniaga Berhad
4.8x-17.2%RM844.9m
SALR SALUS Ljubljana d. d
12xn/a€148.2m

Price-To-Earnings vs Peers: SALR is good value based on its Price-To-Earnings Ratio (12x) compared to the peer average (13.8x).


Price to Earnings Ratio vs Industry

How does SALR's PE Ratio compare vs other companies in the European Healthcare Industry?

Price-To-Earnings vs Industry: SALR is good value based on its Price-To-Earnings Ratio (12x) compared to the European Healthcare industry average (17.2x)


Price to Earnings Ratio vs Fair Ratio

What is SALR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SALR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SALR's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SALR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SALR (€1420) is trading below our estimate of fair value (€13304.96)

Significantly Below Fair Value: SALR is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is SALUS Ljubljana d. d forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


15.9%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SALUS Ljubljana d. d has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether SALUS Ljubljana d. d is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has SALUS Ljubljana d. d performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


31.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SALR has high quality earnings.

Growing Profit Margin: SALR's current net profit margins (2.6%) are lower than last year (3.2%).


Past Earnings Growth Analysis

Earnings Trend: SALR's earnings have grown significantly by 31.9% per year over the past 5 years.

Accelerating Growth: SALR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SALR had negative earnings growth (-4.3%) over the past year, making it difficult to compare to the Healthcare industry average (19.4%).


Return on Equity

High ROE: SALR's Return on Equity (18%) is considered low.


Discover strong past performing companies

Financial Health

How is SALUS Ljubljana d. d's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SALR's short term assets (€131.2M) exceed its short term liabilities (€98.5M).

Long Term Liabilities: SALR's short term assets (€131.2M) exceed its long term liabilities (€9.9M).


Debt to Equity History and Analysis

Debt Level: SALR has more cash than its total debt.

Reducing Debt: SALR's debt to equity ratio has increased from 0.7% to 10.8% over the past 5 years.

Debt Coverage: SALR's debt is well covered by operating cash flow (300.2%).

Interest Coverage: SALR earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is SALUS Ljubljana d. d current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


4.93%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: SALR's dividend (4.93%) is higher than the bottom 25% of dividend payers in the SI market (4.29%).

High Dividend: SALR's dividend (4.93%) is low compared to the top 25% of dividend payers in the SI market (9.15%).


Stability and Growth of Payments

Stable Dividend: SALR's dividend payments have been volatile in the past 10 years.

Growing Dividend: SALR's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (55%), SALR's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (42.1%), SALR's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

SALUS Ljubljana d. d has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

SALUS, Ljubljana, d. d.'s employee growth, exchange listings and data sources


Key Information

  • Name: SALUS, Ljubljana, d. d.
  • Ticker: SALR
  • Exchange: LJSE
  • Founded: 1969
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: €148.213m
  • Shares outstanding: 104.38k
  • Website: https://www.salus.si

Number of Employees


Location

  • SALUS, Ljubljana, d. d.
  • Litostrojska cesta 46 A
  • Ljubljana
  • 1000
  • Slovenia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/17 00:00
End of Day Share Price2022/08/16 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.